Undetectable JC virus CSF PCR in patients with JC virus-induced progressive multifocal leukoencephalopathy. 2023

Chia-Yu Chiu, and Eva Amenta, and Violeta Chavez, and Yuriko Fukuta, and Rodrigo Hasbun
Division of Infectious Diseases, Department of Internal Medicine, The University of Texas Health Science Center at Houston, 6431 Fannin St, STE MSB 2112, Houston, TX, USA. chia-yu.chiu@uth.tmc.edu.

The diagnosis of progressive multifocal leukoencephalopathy (PML) is based on a combination of clinical, radiographic, and laboratory findings. However, negative JC polyomavirus (JCPyV) PCR in CSF does not always rule out JCPyV-related PML. In this narrative review, we sought to examine the characteristic of biopsy-proven PML in patients with undetectable JCPyV CSF PCR and provide alternative approaches in this scenario.

UI MeSH Term Description Entries
D007577 JC Virus A species of POLYOMAVIRUS, originally isolated from the brain of a patient with progressive multifocal leukoencephalopathy. The patient's initials J.C. gave the virus its name. Infection is not accompanied by any apparent illness but serious demyelinating disease can appear later, probably following reactivation of latent virus. Human Polyomavirus JC,JC polyomavirus,Polyomavirus, JC,John Cunningham Virus,Polyomavirus hominis 2,Polyomavirus JC, Human,Virus, John Cunningham
D007968 Leukoencephalopathy, Progressive Multifocal An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7) Encephalitis, JC Polyomavirus,Progressive Multifocal Leukoencephalopathy,JC Polyomavirus Encephalopathy,Encephalopathies, JC Polyomavirus,Encephalopathy, JC Polyomavirus,JC Polyomavirus Encephalitis,Leukoencephalopathies, Progressive Multifocal,Multifocal Leukoencephalopathies, Progressive,Multifocal Leukoencephalopathy, Progressive,Progressive Multifocal Leukoencephalopathies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

Chia-Yu Chiu, and Eva Amenta, and Violeta Chavez, and Yuriko Fukuta, and Rodrigo Hasbun
May 2010, Future virology,
Chia-Yu Chiu, and Eva Amenta, and Violeta Chavez, and Yuriko Fukuta, and Rodrigo Hasbun
February 2003, Nihon rinsho. Japanese journal of clinical medicine,
Chia-Yu Chiu, and Eva Amenta, and Violeta Chavez, and Yuriko Fukuta, and Rodrigo Hasbun
February 1995, Genitourinary medicine,
Chia-Yu Chiu, and Eva Amenta, and Violeta Chavez, and Yuriko Fukuta, and Rodrigo Hasbun
October 2023, Journal of neurovirology,
Chia-Yu Chiu, and Eva Amenta, and Violeta Chavez, and Yuriko Fukuta, and Rodrigo Hasbun
February 2009, Journal of medical microbiology,
Chia-Yu Chiu, and Eva Amenta, and Violeta Chavez, and Yuriko Fukuta, and Rodrigo Hasbun
December 2022, BMC neurology,
Chia-Yu Chiu, and Eva Amenta, and Violeta Chavez, and Yuriko Fukuta, and Rodrigo Hasbun
June 1997, Journal of neuroimmunology,
Chia-Yu Chiu, and Eva Amenta, and Violeta Chavez, and Yuriko Fukuta, and Rodrigo Hasbun
January 1999, Neurology,
Chia-Yu Chiu, and Eva Amenta, and Violeta Chavez, and Yuriko Fukuta, and Rodrigo Hasbun
June 2016, Virologie (Montrouge, France),
Chia-Yu Chiu, and Eva Amenta, and Violeta Chavez, and Yuriko Fukuta, and Rodrigo Hasbun
November 1995, Journal of medical virology,
Copied contents to your clipboard!